3Leung E ,Well DE ,Raviglione M ,et al. The WHO policy package to com- bat antimicrobial resistance[J]. Bull World Health Organ,2011,89 (5): 390-392.
4Hiby N ,Bjamsholt T ,Givskov M ,et al. Antibiotic resistance of bacterial biofilms[J]. Int J Antimicrobial Agents, 2010,35 (4) : 322-332.
5Grundmann H, Klugman KP, Walsh T. A framework for global surveillance of antibiotic resistance[J]. Drug Resist Updat, 2011,14 (2) : 79-87.
6David N, Gilbert, Robert C, et al. The Sanford Guide to Antimicrobial Therapy 2008 [M]. 38th. USA :Antimicrobial Therapy Inc,2008:70-73.
7Li XZ, Nikaido H. Efflux-mediated drug resistance in bacteria:an update[J]. Drugs,2009,69 (12) : 1555-1623.
8Li XZ ,Zhang L, Nikaido H. Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis[J]. Antimicrob Agents Chemother,2004,48 (7) : 2415-2423.
9Li XZ, Nikaido N. Efflux -mediated drug resistance inbacteria:an update[J]. Drugs,2009, 69(12) : 1555.
10Turk S ,Verlaine O ,Gerards T ,et al. New noneovalent inhibitors of peni- cillin-binding proteins from penicillin-resistant bacteria [J]. PLoS One, 2011,6(5) :e19418.
